BugSpeaks is a leading brand in the field of microbiome analysis and interpretation. They work closely with experts from the medical, nutrition, life sciences, and computational biology fields to provide evidence-based analysis. With a focus on genomics data, they have analyzed the genomic signatures of over 100,000 microbial species, accumulating more than 10,000 terabytes of data.

They have successfully executed nearly 1,000 genomics projects for clients from over 10 countries. BugSpeaks is proud to have conducted India's first clinical trial based on the microbiome since their establishment in 2014. As South Asia's first microbiome company, they have made significant contributions to the development of state-of-the-art analytics.

Their expertise has led to the creation of BugSpeaks®, a groundbreaking gut microbiome test. Headquartered in Bengaluru, India's Silicon Valley, BugSpeaks is committed to advancing the understanding and application of microbiome science. Contact them via their website or email to learn more about their innovative products and services